Cargando…
Advanced Glycation End Products Impair Cardiac Atrial Appendage Stem Cells Properties
Background: During myocardial infarction (MI), billions of cardiomyocytes are lost. The optimal therapy should effectively replace damaged cardiomyocytes, possibly with stem cells able to engraft and differentiate into adult functional cardiomyocytes. As such, cardiac atrial appendage stem cells (CA...
Autores principales: | Evens, Lize, Heeren, Ellen, Rummens, Jean-Luc, Bronckaers, Annelies, Hendrikx, Marc, Deluyker, Dorien, Bito, Virginie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269351/ https://www.ncbi.nlm.nih.gov/pubmed/34279448 http://dx.doi.org/10.3390/jcm10132964 |
Ejemplares similares
-
Combinational Therapy of Cardiac Atrial Appendage Stem Cells and Pyridoxamine: The Road to Cardiac Repair?
por: Evens, Lize, et al.
Publicado: (2021) -
The Impact of Advanced Glycation End-Products (AGEs) on Proliferation and Apoptosis of Primary Stem Cells: A Systematic Review
por: Evens, Lize, et al.
Publicado: (2020) -
Differentiation of Human Cardiac Atrial Appendage Stem Cells into Adult Cardiomyocytes: A Role for the Wnt Pathway?
por: Willems, Leen, et al.
Publicado: (2020) -
Glycolaldehyde-modified proteins cause adverse functional and structural aortic remodeling leading to cardiac pressure overload
por: Haesen, Sibren, et al.
Publicado: (2020) -
Acute Exposure to Glycated Proteins Impaired in the Endothelium-Dependent Aortic Relaxation: A Matter of Oxidative Stress
por: D’Haese, Sarah, et al.
Publicado: (2022)